Aurolife Pharma, LLC recalls Glycopyrrolate Tablets, USP, 1 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor…
- Recall date
- May 18, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0877-2023
- FDA classification
- Class III
- Brand / firm
- Aurolife Pharma, LLC
- Sold / distributed
- Nationwide within the United States
Why it was recalled
Failed Impurities/Degradation Specifications
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Glycopyrrolate Tablets, USP, 1 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, NDC 13107-014-01
Get recall alerts
Free email alert whenever Aurolife Pharma, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Aurolife Pharma, LLC